| Name | Description | Data sources | Responsible organisation(s) | Measure methodology last updated |
|---|---|---|---|---|
| Hospital admissions in the general population | This measure shows the rate of hospital admissions with a primary diagnosis of gout in the general population per 100,000. Variation in admission rates due to gout may indicate different admission criteria between districts , poor gout control or limited access to primary care. | National Minimum Dataset (NMDS), Ministry of Health, National Population Projection - Stats NZ | Health Quality & Safety Commission | Te Tāhū Hauora | |
| Dispensed a non-steroidal anti-inflammatory drug | This measure shows the percentage of people with identified gout who were dispensed funded non-steroidal anti-inflammatory drugs (NSAIDs). NSAIDs are often the first line of treatment for acute gout flares and some can be purchased from a pharmacy without a prescription. Although NSAIDs are effective at treating acute gout flares, these medicines have considerable side effects including kidney injury and peptic ulcer disease. | National Minimum Dataset (NMDS), Pharmaceutical Collection (PHARMS), PHO Enrolment Collection, Mortality Collection, NZ Cancer Registry, Ministry of Health, National Population Projection - Stats NZ | Health Quality & Safety Commission | Te Tāhū Hauora | |
| Hospital admissions for people with gout | This measure shows the rate of hospital admissions with a primary diagnosis of gout in those identified with gout per 100,000. Variation in admission rates due to gout may indicate different admission criteria between districts , poor gout control or limited access to primary care. | National Minimum Dataset (NMDS), Pharmaceutical Collection (PHARMS), Primary Health Organisation (PHO) Enrolment Collection, Mortality Collection, NZ Cancer Registry, Ministry of Health, National Population Projection - Stats NZ | Health Quality & Safety Commission | Te Tāhū Hauora | |
| People with diabetes regularly receiving metformin in the relevant year | This indicator shows the number and percent of people with diabetes receiving metformin regularly. Regular use was defined as metformin dispensed in three or more quarters in a year. |
Pharmaceutical Collection (PHARMS), Primary Health Organisation (PHO) Enrolment Collection, Virtual Diabetes Register (VDR) | Health Quality & Safety Commission | Te Tāhū Hauora | June 2024 |
| People with diabetes regularly receiving insulin in the relevant year | This indicator shows the number and percent of people with diabetes dispensed insulin regularly. Regular use was defined as insulin dispensed in three or more quarters in a year. |
Pharmaceutical Collection (PHARMS), Primary Health Organisation (PHO) Enrolment Collection, Virtual Diabetes Register (VDR) | Health Quality & Safety Commission | Te Tāhū Hauora | June 2024 |
| Prevalence of diabetes | This indicator shows the number and percent of the PHO enrolled New Zealand population recorded as having diabetes in the VDR. |
PHO Enrolment Collection, Virtual Diabetes Register (VDR) | Health Quality & Safety Commission | Te Tāhū Hauora | June 2024 |
| People with diabetes having a lower-limb amputation | This indicator shows the number and percent of people with diabetes undergoing a lower-limb amputation. |
National Minimum Dataset (NMDS), Virtual Diabetes Register (VDR) | Health Quality & Safety Commission | Te Tāhū Hauora | June 2024 |
| People with diabetes admitted one or more times to hospital with diabetic ketoacidosis | This measure shows the percentage of people with diabetes admitted to hospital with diabetic ketoacidosis as the primary diagnosis. |
National Minimum Dataset (NMDS), Primary Health Organisation (PHO) Enrolment Collection, Virtual Diabetes Register (VDR) | Health Quality & Safety Commission | Te Tāhū Hauora | June 2024 |
| People with diabetes admitted to hospital with hypoglycaemia | This indicator shows the number and percent of people with diabetes who are admitted to hospital with hypoglycaemia as the primary diagnosis one or more times in the relevant year. |
Pharmaceutical Collection (PHARMS), Primary Health Organisation (PHO) Enrolment Collection, Virtual Diabetes Register (VDR) | Health Quality & Safety Commission | Te Tāhū Hauora | June 2024 |
| People regularly dispensed a short-acting beta agonist (SABA) and not regularly dispensed preventer during the year | This measure details the percentage of PHO-enrolled population aged 5-44 years who are dispensed a short-acting beta-agonist (SABA) in at least two quarters in a year and were not dispensed preventer in two or more quarters in the same year. |
Pharmaceutical Collection (PHARMS), Primary Health Organisation (PHO) Enrolment Collection | Health Quality & Safety Commission | Te Tāhū Hauora | September 2025 |